Behnood Bikdeli on Comparative Effectiveness Research Examples in Thrombosis
Behnood Bikdeli, a cardiologist and vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared an insightful post on X:
“Comparative effectiveness studies can use double-blind RCT, pragmatic RCT, or observational designs with the Target Trial framework.
We break down internal, construct and external validity across designs, with examples in thrombosis.”
Read the full article here.
Title: Comparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations
Authors: Behnood Bikdeli, Joseph S. Ross, Syed Bukhari, Molly M. Jeffery, Gregory Y.H. Lip, Seng Chan You, David J. Cohen, James L. Januzzi Jr, Joshua D. Wallach
Stay informed on the latest scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 2, 2026, 13:16Nathan Connell: Is It Time to Rethink What We Tell Hemophilia B Carriers About Pregnancy?
-
Jul 2, 2026, 13:09Bruce Ovbiagele: WSO SCDKIDS Task Force’s Webinar Sheds Light On Care of Sickle Cell Disease-Related Stroke
-
Jul 2, 2026, 12:55Taraneh G. Farazi: The Latest Stroke Clinician Issue Highlights the Importance of Patient Voices in Dysphagia Care
-
Jul 2, 2026, 12:45Kaveh Mehrvar: The Gut–Brain Axis May Hold New Clues to Stroke Pathophysiology
-
Jul 2, 2026, 12:28Expanding Stroke Education Through Mobile Stroke Clinics – Ethiopia Stroke Foundation
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care
-
Jul 2, 2026, 11:11Safaa Hilal: Improving Postpartum Hemorrhage Outcomes Through Early Warning Scores